Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (5): 319-320.
CHEN Qiaohui, CHEN Dezhi, XU Yanyu, CHEN Zhimin*
Received:2018-01-16
Revised:2019-06-11
Online:2019-05-20
Published:2019-06-11
CLC Number:
CHEN Qiaohui, CHEN Dezhi, XU Yanyu, CHEN Zhimin. One Case of Large Area Skin Rash Induced by Alanyl Glutamine Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(5): 319-320.
| [1] 魏晶,王瑜歆.药品不良反应报告因果关系评价方法概述[J]. 中国药物警戒,2011,8(10):600-602. [2] 陈集志,万平.丙氨酰谷氨酰胺注射液致肝损害伴药疹1例[J]. 中国药师,2014,17(8):1375-1376. [3] 黄静. 14例丙氨酰谷氨酰胺注射液不良反应的文献分析[J]. 海峡药学,2017,29(3):270-271. [4] 杨香瑜,张韶辉,郭珩,等.丙氨酰谷氨酰胺注射液临床应用分析及合理性探讨[J]. 中南药学,2017,15(9):1338-1340. [5] 徐雪梅,王如伟.注射用丙氨酰谷氨酰胺的安全性评价[J]. 中国热带医学,2009,12(9):2313-2314. [6] 王晶,左小霞,张晔.谷氨酰胺临床应用研究进展[J]. 人民军医,2013,56(4):469-470. [7] 刘颖,周海霞,汪晓东,等.丙氨酰-谷氨酰胺二肽临床研究进展[J]. 华西医学,2010,25(7):1382-1384. [8] 曾婷. 丙氨酰谷氨酰胺不合理使用引发的不良反应情况分析[J]. 临床合理用药,2017,10(4C):39-41. [9] 鄢秀英. 静脉滴注丙氨酰谷氨酰胺致过敏反应一例[J]. 华西医学,2012,27(8):1280. [10] 李魏嶙,秦维春.26例丙氨酰谷氨酰胺注射液不良反应分析[J]. 临床合理用药, 2017,10(2C):101-102. [11] 邓永平,杨怀勇.静滴丙氨酰谷氨酰胺致过敏性休克1例[J]. 中外妇儿健康,2011,19(6):285. [12] 张敏娟,徐贞.关于丙氨酰谷氨酰胺注射液的不合理用药分析[J]. 实用药物与临床,2014,17(4):476-477. [13] 周燕萍,龚茜芬,王自强.丙氨酰谷氨酰胺双肽在胃肠道术后应用的安全性和有效性观察[J]. 中国药房,2005,16(17):1321-1323. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
